FDA: BioDelivery Sciences Should Improve “Safe Use” REMS Provisions For Oral Fentanyl Approval
Onsolis “complete response” letter is “as close to approval as one can get without having it,” BDSI CEO says.
Onsolis “complete response” letter is “as close to approval as one can get without having it,” BDSI CEO says.